A Study of Merestinib (LY2801653) in Healthy Participants

Completed · Phase 1

Conditions studied: Healthy

In brief

The purpose of this study is to evaluate the effect of food on merestinib (standard meal and high-fat meal) compared to the fasted state. The study will also measure how much of the study drug gets into the blood stream and how long it takes the body to get rid of it. In addition, the tolerability of the study drug will be evaluated. Information about any side effects that may occur will also be collected. The study will last approximately 28 days. Screening is required within 28 days prior to the start of the study.

Key facts

Study ID
NCT02779738
Run by
Eli Lilly and Company
People needed
24
Starts
2016-05-01
Expected to finish
2016-08-01
Last updated by the study team
2016-08-29

Who can join

Age: 18 and older, up to 65. Sex: any. Healthy volunteers: accepted.

You may qualify if…

You may not qualify if…

Where it is running

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.